Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Surgical Pearls for High Risk Cutaneous Squamous Cell Carcinoma

Description

In a presentation on surgical pearls for managing high-risk cutaneous squamous cell carcinoma (SCC), Dr. Justin Leitenberger discusses key practices and techniques essential for effective treatment. He emphasizes the advantages of peripheral and deep margin assessment (PDEMA) techniques, including Mohs micrographic surgery (MMS), over standard excision methods, highlighting significant reductions in local recurrence, nodal metastasis, and disease-specific mortality associated with MMS. He details surgical strategies, stressing the importance of complete tumor removal during the debulking process and the need for meticulous assessment of margins, particularly in high-risk cases. An illustrative case study on a renal transplant patient with recurrent poorly differentiated SCC illustrates challenges in achieving clear margins and the necessity for careful monitoring. Leitenberger also notes the implications of adjuvant radiation therapy, discussing how wound repair decisions can impact healing and surveillance post-surgery. His conclusions advocate for precise margin control through PDEMA, collaboration with pathologists for additional evaluation, and strategic planning for postoperative care to optimize outcomes in high-risk SCC patients.

View more

Conclusions

  • Margin control using PDEMA is superior to standard excision for managing high-risk cutaneous squamous cell carcinoma (cSCC).
  • Achieving surgically clear margins is essential whenever possible for cSCC.
  • Incorporating debulking procedures with frozen and permanent sections provides additional staging information.
  • Permanent sections should be used judiciously in high-risk and very high-risk cSCC cases.
  • Planning for postoperative radiation therapy and surveillance significantly influences wound repair strategies.
  • Xiong DD, Beal BT, Varra V, Rodriguez M, Cundall H, Woody NM, Vidimos AT, Koyfman SA, Knackstedt TJ. Outcomes in intermediate-risk squamous cell carcinomas treated with Mohs micrographic surgery compared with wide local excision. J Am Acad Dermatol. 2020 May;82(5):1195-1204. doi: 10.1016/j.jaad.2019.12.049. Epub 2019 Dec 27. PMID: 31887322.
  • Stevens JS, Murad F, Smile TD, et al. Validation of the 2022 National Comprehensive Cancer Network Risk Stratification for Cutaneous Squamous Cell Carcinoma. JAMA Dermatol. 2023;159(7):728-735.
  • Thariat J, Carsuzaa F, Beddok A, Deneuve S, Marcy PY, Merlotti A, Dejean C, Devauchelle B. Reconstructive flap surgery in head and neck cancer patients: an interdisciplinary view of the challenges encountered by radiation oncologists in postoperative radiotherapy. Front Oncol. 2024 Apr 11;14:1379861.
  • Michelle et al. JAAD Case Reports,(3) 2023 Volume 33, 1 - 3.
  • Sven Zürcher *, Zora Martignoni, Robert E. Hunger, Michael Benzaquen and S. Morteza Seyed Jafari. Mohs Micrographic Surgery for Cutaneous Squamous Cell Carcinoma. Systematic Review. MDPI, Systematic review 2024.